WASHINGTON–President Donald Trump and his administration have negotiated a deal with EMD Serono, a leading fertility drug manufacturer, to radically reduce the cost of in vitro fertilization drug prices.
The medication Gonal-f will be sold at a major discount in the United States, which the White House noted is “equal to 796% of the deal price,” via purchase through the TrumpRx.gov, with women who qualify as low or middle-income who buy from the website, which is set to launch in January, getting “an additional discount totaling 2,320% of the deal price.”
As EMD Serono noted in a press release:
As part of the agreement, EMD Serono will offer Direct-to-Consumer (DTC) sales of its complete portfolio of IVF therapies, including Gonal-f® (follitropin alfa injection), Ovidrel® (choriogonadotropin
Join the conversation!
Please share your thoughts about this article below. We value your opinions, and would love to see you add to the discussion!